Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OCTA Evaluated the Efficacy of Glucocorticoid Retrobulbar Injection in the Treatment of Retinal Photo-injury

NCT07869511 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT07869511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OCTA Evaluated the Efficacy of Glucocorticoid Retrobulbar Injection in the Treatment of Retinal Photo-injury
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Overall status
Recruiting
Start date
October 9, 2026
Completion date
October 9, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photic maculopathy, photic retinopathy, retinal light damage